Syngene International LtdSyngene International Ltd - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

Alternative corporations in the scoring peer group for Syngene International Ltd are shown below. Browse to the end of the webpage for potential risks for Syngene International Ltd based on industry, location and size. Full Sustainability analysis of Syngene International Ltd can be reached by registering for free.

Syngene International Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 7.9; made up of an environmental score of 8.0, social score of 8.0 and governance score of 7.0.

SDG Transparency Score for Syngene International Ltd 
Low
0 - 3
Medium
4 - 6

7.9

High Impact
7 - 10
Last Score Update: 2023-07-01
What drives the score for Syngene International Ltd 
8.0

Environmental

8.0

Social

7.0

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
55Wai Yuen Tong Medicine Holdings Ltd
8.0
High
55Zota Health Care Ltd
8.0
High
174Syngene International Ltd
7.9
High
174Biogen Inc
7.9
High
174Clinigen Group PLC
7.9
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Syngene International Ltd have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Syngene International Ltd disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Syngene International Ltd report the average age of the workforce?

LockedSign up for free to unlock

Does Syngene International Ltd reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Syngene International Ltd disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Syngene International Ltd disclose cybersecurity risks?

LockedSign up for free to unlock

Does Syngene International Ltd offer flexible work?

LockedSign up for free to unlock

Does Syngene International Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Syngene International Ltd disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Syngene International Ltd conduct supply chain audits?

LockedSign up for free to unlock

Does Syngene International Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Syngene International Ltd conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Syngene International Ltd disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Syngene International Ltd disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Syngene International Ltd disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Syngene International Ltd disclose water use targets?

LockedSign up for free to unlock

Does Syngene International Ltd have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Syngene International Ltd have a product recall in the last two years?

LockedSign up for free to unlock

Does Syngene International Ltd disclose incidents of discrimination?

LockedSign up for free to unlock

Does Syngene International Ltd allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Syngene International Ltd issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Syngene International Ltd disclose parental leave metrics?

LockedSign up for free to unlock

Does Syngene International Ltd disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Syngene International Ltd disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Syngene International Ltd disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Syngene International Ltd support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Syngene International Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Syngene International Ltd reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Syngene International Ltd involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Syngene International Ltd disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Syngene International Ltd disclose its waste policy?

LockedSign up for free to unlock

Does Syngene International Ltd report according to TCFD requirements?

LockedSign up for free to unlock

Does Syngene International Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Syngene International Ltd disclose energy use targets?

LockedSign up for free to unlock

Does Syngene International Ltd disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Syngene International Ltd have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Syngene International Ltd
These potential risks are based on the size, segment and geographies of the company.

Syngene International Limited, a contract research and manufacturing company, provides drug discovery and development services in India, the United States, and internationally. The company provides discovery chemistry services, such as medicinal and synthetic chemistry, library and peptide synthesis, biomolecules, organic electronic materials, and computational and analytical chemistry; and discovery biology services in the areas of recombinant DNA engineering, cell line development, hybridoma technology, sequencing, protein sciences, screening and assay biology, DMPK, in vivo pharmacology, toxicology, and biologicals. It also offers exploratory/discovery, in vitro and genetic, and developmental and reproductive toxicology services, as well as acute, sub-chronic, and chronic toxicity studies; and chemical, formulation, analytical, and clinical development services, as well as commercial manufacturing services. In addition, the company provides lead generation, preclinical development, API, and drug product development services; and clinical trial management, pharmacokinetic analysis/bioanalytical, central lab, biometrics and clinical data management, regulatory, medical monitoring, pharmacovigilance, and medical writing services. Further, it offers other drug modalities, which include peptides, oligonucleotide synthesis, antibody drug conjugate, PROTACs, and CAR T-cell therapy services. The company serves pharmaceutical, biotechnology, nutrition, animal health, consumer goods, specialty chemical, and other companies. It has partnerships and collaborations with Bristol-Myers Squibb Co.; Baxter Inc.; and Amgen Inc. The company was incorporated in 1993 and is headquartered in Bengaluru, India. Syngene International Limited is a subsidiary of Biocon Limited.

Sorry!

Failed to process!